<html>
<head>PUBMED IDs for PTPN21</head>
<body bgcolor='#C5F0F2'><h1>PTPN21</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14965469/'>Inferred functions of &quot;novel&quot; genes identified in fibroblasts chondroinduced by demineralized bone.</a> February 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16918960/'>Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.</a> August 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20361941/'>Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.</a> May 27  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21752600/'>Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia.</a> December 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25681686/'>PTPN21 exerts pro-neuronal survival and neuritic elongation via ErbB4/NRG3 signaling.</a> August 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26527318/'>Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.</a> November 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26771814/'>High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity.</a> October 14  2016<br></body></html>
